Racial Comparisons of Health Care and Glycemic Control for African American and White Diabetic Adults in an Urban Managed Care Organization

2004 ◽  
Vol 7 (1) ◽  
pp. 25-34 ◽  
Author(s):  
Tiffany L. Gary ◽  
Maura McGuire ◽  
Jeanne McCauley ◽  
Frederick L. Brancati
2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Saba W. Masho ◽  
Susan Cha ◽  
RaShel Charles ◽  
Elizabeth McGee ◽  
Nicole Karjane ◽  
...  

Background. Delays in postpartum contraceptive use may increase risk for unintended or rapid repeat pregnancies. The postpartum care visit (PPCV) is a good opportunity for women to discuss family planning options with their health care providers. This study examined the association between PPCV attendance and modern contraceptive use using data from a managed care organization. Methods. Claims and demographic and administrative data came from a nonprofit managed care organization in Virginia (2008–2012). Information on the most recent delivery for mothers with singleton births was analyzed (N = 24,619). Routine PPCV (yes, no) and modern contraceptive use were both dichotomized. Descriptive analyses provided percentages, frequencies, and means. Multiple logistic regression was conducted and ORs and 95% CIs were calculated. Results. More than half of the women did not attend their PPCV (50.8%) and 86.9% had no modern contraceptive use. After controlling for the effects of confounders, women with PPCV were 50% more likely to use modern contraceptive methods than women with no PPCV (OR = 1.50, 95% CI = 1.31, 1.72). Conclusions. These findings highlight the importance of PPCV in improving modern contraceptive use and guide health care policy in the effort of reducing unintended pregnancy rates.


2001 ◽  
Vol 51 (2) ◽  
pp. 243-263 ◽  
Author(s):  
Nicolas T. Taylor ◽  
Gary M. Burlingame ◽  
Kristoffer B. Kristensen ◽  
Addie Fuhriman ◽  
Justin Johansen ◽  
...  

2006 ◽  
Vol 41 (5) ◽  
pp. 477-481
Author(s):  
J. Russell Teagarden

Managed care pharmacists are involved formally with the interface between the delivery and financing of health care; their work thus entails an accountability for both elements. Interpreted broadly, managed care pharmacists are pharmacists working within the sphere of a health care system, health care purchaser, health insurer, managed care organization, or benefit administration agency. Patients, the pharmacy profession, and society are best served by this broad interpretation, because the interdependency of financing and delivery is inextricably linked to the achievement of good health outcomes. This continuing feature will explore contemporary issues facing managed care pharmacists.


2003 ◽  
Vol 38 (3) ◽  
pp. 271-274 ◽  
Author(s):  
J. Russell Teagarden

Managed care pharmacists are involved formally with the interface between the delivery and financing of health care; their work thus entails an accountability for both elements. Interpreted broadly, managed care pharmacists are pharmacists working within the sphere of a health care system, health care purchaser, health insurer, managed care organization, or benefit administration agency. Patients, the pharmacy profession, and society are best served by this broad interpretation, because the interdependency of financing and delivery is inextricably linked to the achievement of good health outcomes. This continuing feature will explore contemporary issues facing managed care pharmacists.


2008 ◽  
Vol 70 (2) ◽  
Author(s):  
Courtney Lyons Snyder

A recent transplant case raises an interesting question: Should a managed care organization (“MCO”) face criminal prosecution when a patient dies after the MCO’s decision to deny payment for treatment? Is providing such a legal cause of action the solution, or does doing so just put money into the pockets of attorneys rather than into the hands of the injured health care consumer? As a recent case suggests, bad publicity could be as effective a deterrent as any criminal prosecution in changing an MCO’s behavior.


Sign in / Sign up

Export Citation Format

Share Document